FDA Approves ALS Treatment Despite Questions About Effectiveness
The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.
Stay updated with breaking news from Billy Dunn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.
A drug from Amylyx Pharmaceuticals to treat ALS, or Lou Gehrig’s disease, won U.S. approval on Thursday from the Food and Drug Administration based on the results of a small, mid-stage study.
U.S. health officials have approved a much-debated drug to treat the deadly illness known as Lou Gehrig's disease.
U.S. health officials have approved a much-debated drug to treat the deadly illness known as Lou Gehrig's disease
WASHINGTON (AP) -- A much-debated drug for Lou Gehrig's disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew